Anthony Villano, MD

Have an interest in Surgical Oncology and research? We’re now accepting applications for our 2-year CGSO research fellowship! See our website below for details and instructions @FoxChaseCancer @FoxChaseSurgOnc @SocSurgOnc @SanjaySReddy @JeffreyFarma foxchase.org/research-train…

Great talk today on from our graduating breast fellowship @WalkerLyonsMD and soon to be @FoxChaseSurgOnc faculty on de-escalation of care in #breastcancer @FoxChaseCancer @TempleHealth @ASBrS @SocSurgOnc @AmCollSurgeons @LivingBeyondBC @SusanGKomen @AmBdSurg @JEFFsurgery

Looking forward to a great conversation. Outstanding resource for trainees from @SSATNews, worth a listen if your @AmBdSurg boards are coming up 📚. Join us!

Very cool series from @SSATNews! Proud/fortunate to work with @JeffreyFarma @FoxChaseCancer @FoxChaseSurgOnc. Nice work by @ChataniMD leading this discussion💪🏻

Congrats to @KamekoKarasaki @HawaiiSurgery, Nicholas Michael @WRNMMC_DHA, and Saniya Ablatt @VMFHealth on joining the @FoxChaseCancer @TempleHealth family! Thrilled with the new additions! @SocSurgOnc @JeffreyFarma @AndreaSurg1

Honored to host @bermar01 @FoxChaseSurgOnc for our inaugural endowed lecture in the Department of Surgery @FoxChaseCancer learning from the ultimate #Mentor @SocSurgOnc @AmCollSurgeons @TempleHealth @WeillCornell @AmBdSurg @AcademicSurgery

Congratulations to @FoxChaseSurgOnc @stephaniehgreco on her promotion to Associate Professor and @SanjaySReddy to Professor- so lucky to work with such amazing #Surgeons @FoxChaseCancer @TempleHealth @AcademicSurgery @AmCollSurgeons @AmColSurgCancer @SocSurgOnc

Fragmented Care Does Not Affect Survival Outcomes for Retroperitoneal Sarcoma, Fox Chase Cancer Center Study Finds @FoxChaseCancer #Sarcoma #Oncology onclive.com/view/fragmente…

Excellent talk on Quality and the history of the @AmCollSurgeons and @AmColSurgCancer @FoxChaseCancer with @jamessunmd @FoxChaseSurgOnc @TempleHealth

…and that’s a wrap! Wonderful presentation by @emily_papai on #duration vs #modality  in NAT for PDAC 💜 Great final session #DDW2025 @SSATNews🔥 @TempleSurgRes @TempleHealth @FoxChaseCancer @PanCAN @PanCANPhilly @AMVillanoMD

#CincoDeMayo #CincoDeMayo2025 @FoxChaseSurgOnc with our festive team! @FoxChaseCancer @TempleHealth @AmCollSurgeons @SocSurgOnc @NCCN

So proud of our @FoxChaseSurgOnc #surgicaloncology research residents @emily_papai and Jenny Hwang for another successful @SSATNews @PancreasClub #DDW2025 presentations #pancreascancer 💜 Also, congrats to @templemedschool #MS2 Hal Rives for his 1st national meeting presenting!…

“My hope is that if every institution throughout the country can have a young adult cancer program, even something small...can provide a large impact for patients,” says @ChrisCannMD in a recent article with @Medscape: wb.md/43XTly3

We're proud to share that Fox Chase Cancer Center's @SanjaySReddy, MD, recently completed the @SocSurgOnc's Career Catalyst Mentorship Program (CCMP), which is a one-year program that provides career and leadership development opportunities for mid-career surgical oncologists.

Thought provoking work from @tarik_sammour et al. in @AnnSurgOncol 💯 The local regrowth trend stratified by KRAS is interesting and could certainly shape expectations. Would love to see oncologic outcomes for salvage surgery stratified by KRAS 🧐

Results from a study presented by Fox Chase's Hannah Buettner, MD, at the @SocSurgOnc 2025 Annual Meeting suggest that chemotherapy followed by local excision is a promising treatment option for patients with node-negative low rectal cancer: bit.ly/43zZuAf

Excellent presentation @hannahbuettner CGSO Fellow @FoxChaseSurgOnc on our @FoxChaseCancer Rectal Preservation Trial supported by @gyrig @SocSurgOnc #SSO2025 #coloncancer @TempleMedNews @joshmeyer1

#SSO2025 Great debate with our @FoxChaseSurgOnc Chair @JeffreyFarma center stage fostering a thoughtful discussion on the role of APPs in trainee education 🙏🏻

Happening now! @WalkerLyonsMD @FoxChaseSurgOnc Breast Fellow presenting on Management and outcomes in #breastcancer patients with 1-1 and 2-2 positive sentinel lymph nodes @SocSurgOnc #SSO2025 @ASBrS @AmColSurgCancer @TempleMedNews

All-star 1st year FCCC fellow @ChataniMD discussing why we should consider moving the goalpost up a bit for lymph node targets in colon cancer! Proud of all his work on an important topic with measurable benefits! 💯🔥@FoxChaseSurgOnc #SSO2025